191 related articles for article (PubMed ID: 37063842)
1. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant pleural effusions: the case for localized immunotherapy.
Donnenberg AD; Luketich JD; Dhupar R; Donnenberg VS
J Immunother Cancer; 2019 Apr; 7(1):110. PubMed ID: 30999958
[TBL] [Abstract][Full Text] [Related]
3. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer.
Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M
Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469
[TBL] [Abstract][Full Text] [Related]
4. Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications.
Donnenberg AD; Luketich JD; Donnenberg VS
Oncotarget; 2019 Nov; 10(60):6456-6465. PubMed ID: 31741710
[TBL] [Abstract][Full Text] [Related]
5. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
[TBL] [Abstract][Full Text] [Related]
6. IL-26 promotes the pathogenesis of malignant pleural effusion by enhancing CD4
Niu Y; Ye L; Peng W; Wang Z; Wei X; Wang X; Li Y; Zhang S; Xiang X; Zhou Q
J Leukoc Biol; 2021 Jul; 110(1):39-52. PubMed ID: 33847412
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.
Chen YM; Tsai CM; Whang-Peng J; Perng RP
J Interferon Cytokine Res; 2001 Apr; 21(4):249-56. PubMed ID: 11359656
[TBL] [Abstract][Full Text] [Related]
8. IL-12 conditioning of peripheral blood mononuclear cells from breast cancer patients promotes the zoledronate-induced expansion of γδ T cells in vitro and enhances their cytotoxic activity and cytokine production.
Assy L; Khalil SM; Attia M; Salem ML
Int Immunopharmacol; 2023 Jan; 114():109402. PubMed ID: 36481526
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer.
Hu CY; Zhang YH; Wang T; Chen L; Gong ZH; Wan YS; Li QJ; Li YS; Zhu B
Clin Exp Immunol; 2016 Oct; 186(1):106-14. PubMed ID: 27447482
[TBL] [Abstract][Full Text] [Related]
10. Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion.
Niu Y; Zhou Q
Cell Mol Life Sci; 2022 Mar; 79(4):194. PubMed ID: 35298721
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma.
DeLong P; Carroll RG; Henry AC; Tanaka T; Ahmad S; Leibowitz MS; Sterman DH; June CH; Albelda SM; Vonderheide RH
Cancer Biol Ther; 2005 Mar; 4(3):342-6. PubMed ID: 15846066
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher levels of IL-2 and IL-6 than those released by PBMC.
Mantovani G; Macciò A; Versace R; Pisano M; Lai P; Esu S; Ghiani M; Dessì D; Turnu E; Santona MC
J Mol Med (Berl); 1995 Aug; 73(8):409-16. PubMed ID: 8528743
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CC-chemokine ligand 18 (CCL18) in the serum and pleural effusion of non-small-cell lung cancer patients and its regulatory effect on the differentiation of monocyte-derived dendritic cells].
Chen L; Zhou Q; Zhong F; Wang Q; Fang Y; Yang K; Guan S
Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):823-7. PubMed ID: 25620478
[TBL] [Abstract][Full Text] [Related]
14. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
[TBL] [Abstract][Full Text] [Related]
15. C5a enhances inflammation and chemotaxis of γδ T cells in malignant pleural effusion.
Deng S; Jiang Y; Luo L; Tang H; Hu X; Wu C; Tang J; Ge H; Gong X; Cai R; Wang G; Li X; Feng J
Int Immunopharmacol; 2024 Jan; 127():111332. PubMed ID: 38071913
[TBL] [Abstract][Full Text] [Related]
16. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
17. Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.
Scherpereel A; Grigoriu BD; Noppen M; Gey T; Chahine B; Baldacci S; Trauet J; Copin MC; Dessaint JP; Porte H; Labalette M
BMC Cancer; 2013 Jul; 13():324. PubMed ID: 23816056
[TBL] [Abstract][Full Text] [Related]
18. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.
Ye ZJ; Zhou Q; Yin W; Yuan ML; Yang WB; Xiong XZ; Zhang JC; Shi HZ
Am J Respir Crit Care Med; 2012 Dec; 186(11):1168-79. PubMed ID: 23065014
[TBL] [Abstract][Full Text] [Related]
19. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
20. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
